编号 | 通路 | Count | 基因 | PValue |
hsa05200 | Pathways in cancer | 25 | PIK3CG, EGFR, AR, IL6, PPARD, PTGS2, RXRB, RXRA, PPARG, TP53, RB1, CDK4, MMP2, MMP1, CDK2, MAPK1, JUN, BCL2, GSK3B, VEGFA, MAPK8, PRKACA, NOS2, EGF, GSTP1 | 9.83E−09 |
hsa04020 | Calcium signaling pathway | 17 | EGFR, DRD1, CACNA1S, CHRM5, ADRB2, ADRB1, CHRM3, CHRM2, CHRM1, ADRA1B, ADRA1A, CHRNA7, NOS3, PRKACA, NOS2, ADRA1D, HTR2A | 2.14E−08 |
hsa04080 | Neuroactive ligand-receptor interaction | 20 | OPRM1, GABRA2, DRD1, GABRA1, PRSS1, NR3C1, CHRM5, ADRB2, ADRB1, CHRM3, CHRM2, CHRM1, F2, ADRA1B, ADRA1A, CHRNA7, ADRA1D, HTR2A, CHRNA2, OPRD1 | 6.94E−08 |
hsa04668 | TNF signaling pathway | 13 | PIK3CG, IL6, TNF, CCL2, PTGS2, MMP3, VCAM1, MAPK1, MAPK14, JUN, IL1B, MAPK8, SELE | 1.18E−07 |
hsa05219 | Bladder cancer | 9 | EGFR, MAPK1, VEGFA, TP53, RB1, EGF, CDK4, MMP2, MMP1 | 2.19E−07 |
hsa04066 | HIF-1 signaling pathway | 12 | PIK3CG, EGFR, MAPK1, IL6, HMOX1, BCL2, VEGFA, IFNG, NOS3, NOS2, EGF, INSR | 3.28E−07 |
hsa05142 | Chagas disease (American trypanosomiasis) | 12 | PIK3CG, MAPK1, IL6, TNF, CCL2, MAPK14, JUN, IFNG, IL1B, MAPK8, NOS2, IL2 | 7.44E−07 |
hsa05223 | Non-small cell lung cancer | 9 | PIK3CG, EGFR, MAPK1, RXRB, RXRA, TP53, RB1, EGF, CDK4 | 2.66E−06 |
hsa05222 | Small cell lung cancer | 10 | PIK3CG, PTGS2, RXRB, RXRA, BCL2, TP53, RB1, NOS2, CDK4, CDK2 | 7.92E−06 |
hsa05212 | Pancreatic cancer | 9 | PIK3CG, EGFR, MAPK1, VEGFA, TP53, MAPK8, RB1, EGF, CDK4 | 8.38E−06 |
hsa04151 | PI3K-Akt signaling pathway | 19 | EGFR, PIK3CG, IL6, RXRA, TP53, CDK4, CDK2, KDR, MAPK1, CHRM2, BCL2, GSK3B, CHRM1, VEGFA, NOS3, COL1A1, EGF, INSR, IL2 | 8.53E−06 |
hsa04725 | Cholinergic synapse | 11 | PIK3CG, MAPK1, ACHE, CHRM5, CHRM3, CHRM2, CHRM1, BCL2, PRKACA, CHRNA7, CACNA1S | 1.05E−05 |
hsa05215 | Prostate cancer | 10 | PIK3CG, EGFR, MAPK1, AR, BCL2, GSK3B, TP53, RB1, EGF, CDK2 | 1.06E−05 |
hsa05161 | Hepatitis B | 12 | PIK3CG, MAPK1, IL6, TNF, JUN, BCL2, TP53, MAPK8, RB1, CDK4, CCNA2, CDK2 | 1.94E−05 |
hsa04915 | Estrogen signaling pathway | 10 | OPRM1, PIK3CG, EGFR, MAPK1, JUN, ESR1, PRKACA, NOS3, ESR2, MMP2 | 2.76E−05 |